Publication Date:
1984-01-06
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Culliton, B J -- New York, N.Y. -- Science. 1984 Jan 6;223(4631):35.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/6691133" target="_blank"〉PubMed〈/a〉
Keywords:
*Advisory Committees
;
*DNA, Recombinant
;
*Federal Government
;
*Government Regulation
;
*National Institutes of Health (U.S.)
;
United States
;
Recombinant DNA Advisory Committee (RAC) are seen as potentially detrimental to
;
RAC's credibility. Each session was closed on grounds that proprietary data were
;
being reviewed. NIH Director James B. Wyngaarden has implemented a formal review
;
of the extent of the authority of RAC, which currently reviews not only research
;
projects funded by its parent agency but also voluntarily-submitted industrial
;
proposals and proposals of other federal government agencies.
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics